DCM
HSTO

Driehaus Capital Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Driehaus Capital Management’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-114
Closed -$185K – 651
2014
Q1 		$185K Buy
+114
New +$238K 0.01% 488

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return

Driehaus Capital Management's HSTO Position: Q2 2014 in Review

Driehaus Capital Management sold out of Histogen Inc. Common Stock (HSTO) in Q2 2014, closing a stake of 114 shares — an estimated $185K sold.

Driehaus Capital Management first reported a position in HSTO in Q1 2014 and held it in 1 quarter. The position peaked at $185K in Q1 2014. 38 funds tracked by Wall St. Rank hold HSTO as of Q2 2014.

  • Driehaus Capital Management reported no remaining Histogen Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Driehaus Capital Management sold 114 Histogen Inc. Common Stock shares in Q2 2014, an estimated $185K.
  • Driehaus Capital Management first reported a position in Histogen Inc. Common Stock in Q1 2014 and held it in 1 quarter.
  • Driehaus Capital Management's Histogen Inc. Common Stock position peaked at $185K in Q1 2014.
  • 38 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2014.

Based on Driehaus Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.